RileyTRBhattiAM. Preventive strategies in chronic liver disease: Part I. Alcohol, vaccines, toxic medications and supplements, diet and exercise. Am Fam Physician2001;64(9):1555–60.
2.
SchrierRWGambertoglioJG, editors. Handbook of drug therapy in liver and kidney disease. Toronto: Little, Brown and Company; 1991.
3.
WestphalJ-FBrogardJ-MDrug administration in chronic liver disease. Drug Safe1997;17(1):47–73.
4.
VerbeeckRKHorsmansY. Effect of hepatic insufficiency on pharmacokinetics and drug dosing. Pharm World Sci1998;20(5):183–92.
TolmanKG. Hepatotoxicity of non-narcotic analgesics. Am J Med1998;105(1B):13S–19S.
7.
LeeWM. Drug-induced hepatotoxicity. N Engl J Med2003;349(5):474–85.
8.
HitchensK. Monitoring liver damage. Drug Topics2002;4:46–48, 52.
9.
McLeanAJMorganDJ. Clinical pharmacokinetics in patients with liver disease. Clin Pharmacokinet1991;21(1):42–69.
10.
MontaukSLRheinsteinPH. Appropriate use of common OTC analgesics and cough and cold medications. An American Family Physician Monograph. No. 1, 2002. American Academy of Family Physicians. Available: www.aafp.org/afp/otcmonograph/index2.html (accessed March 12, 2004).
11.
McEvoyGK, editor. AHFS drug information service. 45th edition. Bethesda, MD: American Society of Health-System Pharmacists, 2003.
12.
Di BisceglieAMPreventative strategies for chronic liver disease. Am Fam Physician2001;64(9):1515–6.
13.
RileyTRBhattiAM. Preventative strategies in chronic liver disease: Part II. Cirrhosis. Am Fam Physician2001;64(10):1735–40.
